Biotechnology Company Signs Major Contract To Source Distributors and Manufacturers

Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on the discovery and development of novel psychedelic-derived therapeutics, has announced a engagement with JS First Sdn. Bhd (“JS First”). This partnership focuses on sourcing global manufacturers and distributors for Clearmind's groundbreaking MEAI-based alcohol substitute beverages, marking a massive step towards international expansion. $Clearmind Medicine(CMND.US)$